| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2013 | US8486994 Prodrugs of substituted 1,3-dioxanes and their uses |
| 07/16/2013 | US8486993 Solid dispersions comprising tacrolimus |
| 07/16/2013 | US8486992 Carboxamide derivatives as muscarinic receptor antagonists |
| 07/16/2013 | US8486991 Enantiomerically pure phosphoindoles as HIV inhibitors |
| 07/16/2013 | US8486990 SirT inhibitors that bind to NAD |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486988 Crystalline chemotherapeutic |
| 07/16/2013 | US8486987 Mechanism-based small-molecule parasite inhibitors |
| 07/16/2013 | US8486984 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/16/2013 | US8486983 Self-emulsifying formulations of CETP inhibitors |
| 07/16/2013 | US8486982 1,2,4-oxadiazole benzoic acids |
| 07/16/2013 | US8486981 Selective ligands for the dopamine 3 (D3) receptor and methods of using the same |
| 07/16/2013 | US8486980 Tricyclic compound |
| 07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
| 07/16/2013 | US8486978 Compositions and methods for treating diseases of the nail |
| 07/16/2013 | US8486977 1,2,3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors |
| 07/16/2013 | US8486976 Enhanced migraine treatments based on ghrelin mimetics |
| 07/16/2013 | US8486975 Non-nucleoside reverse transcriptase inhibitors |
| 07/16/2013 | US8486974 Efficient aspirin prodrugs |
| 07/16/2013 | US8486973 Sublingual fentanyl spray |
| 07/16/2013 | US8486972 Sublingual fentanyl spray |
| 07/16/2013 | US8486971 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof |
| 07/16/2013 | US8486970 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 07/16/2013 | US8486969 Therapeutic compounds |
| 07/16/2013 | US8486968 Compounds |
| 07/16/2013 | US8486967 Heteroaryl substituted piperidines |
| 07/16/2013 | US8486966 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer |
| 07/16/2013 | US8486965 Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer |
| 07/16/2013 | US8486964 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/16/2013 | US8486963 Azaindolizines and methods of use |
| 07/16/2013 | US8486962 N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus |
| 07/16/2013 | US8486961 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use |
| 07/16/2013 | US8486960 Formulations and methods for vascular permeability-related diseases or conditions |
| 07/16/2013 | US8486959 Dibenzo[f,h]isoquinoline derivatives |
| 07/16/2013 | US8486957 Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway |
| 07/16/2013 | US8486956 Forms of rifaximin and uses thereof |
| 07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
| 07/16/2013 | US8486954 Heterobicyclic carboxamides as inhibitors for kinases |
| 07/16/2013 | US8486953 Thienopyrimidines for pharmaceutical compositions |
| 07/16/2013 | US8486952 Compounds for the reduction of β-amyloid production |
| 07/16/2013 | US8486950 Janus kinase inhibitor compounds and methods |
| 07/16/2013 | US8486949 Use of azaperone for improving growth performance |
| 07/16/2013 | US8486948 Piperazinodihydrothienopyrimidine derivatives |
| 07/16/2013 | US8486947 Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands |
| 07/16/2013 | US8486946 Pyrazolo [4,3-c] cinnolin-3-one M1 receptor positive allosteric modulators |
| 07/16/2013 | US8486945 Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system |
| 07/16/2013 | US8486943 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 07/16/2013 | US8486942 Modulators of pharmacokinetic properties of therapeutics |
| 07/16/2013 | US8486941 Phenyl amino pyrimidine compounds and uses thereof |
| 07/16/2013 | US8486940 Inhibitors |
| 07/16/2013 | US8486939 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 07/16/2013 | US8486938 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
| 07/16/2013 | US8486937 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof |
| 07/16/2013 | US8486936 Antagonist of smoothened |
| 07/16/2013 | US8486935 Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine |
| 07/16/2013 | US8486933 Pyrimidine inhibitors of kinase activity |
| 07/16/2013 | US8486932 Triazole compounds that modulate Hsp90 activity |
| 07/16/2013 | US8486931 Substituted oxindole compounds |
| 07/16/2013 | US8486930 Salts |
| 07/16/2013 | US8486929 Combination medicaments for treating bacterial infections |
| 07/16/2013 | US8486928 Super-oxide dismutase mimetics |
| 07/16/2013 | US8486927 Crystalline forms of lamotrigine |
| 07/16/2013 | US8486926 Steroid tetrol solid state forms |
| 07/16/2013 | US8486925 Testosterone gel and method of use |
| 07/16/2013 | US8486924 Taxane delivery system |
| 07/16/2013 | US8486923 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 07/16/2013 | US8486922 Composition |
| 07/16/2013 | US8486921 Synthesis of tetracyclines and analogues thereof |
| 07/16/2013 | US8486919 4-alkylresorcinol derivative and external preparation for skin containing the same |
| 07/16/2013 | US8486918 Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor |
| 07/16/2013 | US8486916 Medicine, food and drink or feed containing sphingomyelin |
| 07/16/2013 | US8486914 Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses |
| 07/16/2013 | US8486911 Th1-associated microRNAs and their use for tumor immunotherapy |
| 07/16/2013 | US8486904 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 07/16/2013 | US8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 07/16/2013 | US8486901 Sodium channel blocking compounds tetrodotoxin galactopyranosides |
| 07/16/2013 | US8486900 Method for preparing a Centella asiatica extract rich in madecassoside and in terminoloside |
| 07/16/2013 | US8486899 Antioxidant |
| 07/16/2013 | US8486898 Compounds and method for inhibiting the activity of gelatinase and collagenase |
| 07/16/2013 | US8486897 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 07/16/2013 | US8486859 Plant growth regulatoirs |
| 07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |
| 07/16/2013 | US8486656 Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486462 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 07/16/2013 | US8486457 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 07/16/2013 | US8486456 Itraconazole compositions with improved bioavailability |
| 07/16/2013 | US8486452 Stabilized tolterodine tartrate formulations |
| 07/16/2013 | US8486446 Oral antimicrobial pharmaceutical compositions |
| 07/16/2013 | US8486445 Self-microemulsifying mitotane composition |
| 07/16/2013 | US8486442 External patch containing estrogen and/or progestogen |
| 07/16/2013 | US8486428 Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles |
| 07/16/2013 | US8486426 Use of topical delivery vehicles, including hydrogels, which incorporate active agents such as organic acids; especially containing a humectant and having a moisture content effective to create a diffusion gradient |
| 07/16/2013 | US8486425 Two-phase sunscreen composition |
| 07/16/2013 | US8486423 Thermo-kinetic mixing for pharmaceutical applications |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486387 Modified two-component gelation systems, methods of use and methods of manufacture |
| 07/16/2013 | US8486386 Modified two-component gelation systems, methods of use and methods of manufacture |
| 07/16/2013 | US8486382 Method for treating cervical cancer |
| 07/16/2013 | US8486381 Methods of modulating intestinal fluid balance |